Rivaroxaban Versus Warfarin for the Treatment of Cerebral Venous Thrombosis (RWCVT): A Randomized Controlled Trial in Resource-Limited Setting.

Stroke Res Treat · 2025 · PMC12081145 · PMID 40376280

Europe PMC DOI

hedged sentence

0.2700

closest p · 5.4× alpha

0.2700

boldest claim

The sentences

did not reach statistical significancep = 0.27not close (p > 0.1)

Cox regression revealed a hazard ratio of 1.41 (0.77–2.59), which did not reach statistical significance ( χ 2 = 1.24, p = 0.27).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.